PACIFIC-DRILLING
13.5.2019 22:32:04 CEST | Business Wire | Press release
Pacific Drilling S.A. (NYSE: PACD) (“Pacific Drilling” or the “Company”) today reported results for the first quarter of 2019. Net loss for the first-quarter 2019 was $84.0 million or $1.12 per diluted share. EBITDA(a) for the first-quarter 2019 was $1.9 million.
“Our strong operational performance, reflected by 98.1% revenue efficiency for the quarter, and focus on spend management, delivered improved results and positive EBITDA for the quarter. We continue to make changes in our supply chain and maintenance processes that meaningfully reduce our operating costs while delivering safe, reliable and efficient operations,” said CEO Bernie Wolford.
“While the market remains challenging, we are encouraged by the upturn in utilization within the sector and continued improvement in demand as indicated by tender activity and direct discussions with clients. We are ideally positioned to benefit from this increasing demand for our available 6th and 7th generation drillships.”
“The contract with Equinor for the Pacific Khamsin is a clear acknowledgement of our record of delivering exceptional performance. Having capable and experienced crews maintaining our smart-stacked rigs supported by a strong technical team committed to performance will allow us to deliver the 7th generation Pacific Khamsin drillship in a ready to work condition with economy and efficiency. Additionally, our integrated service experience will play a key role in providing Equinor with a package of services in support of their success.”
First-Quarter 2019 Operational and Financial Commentary
First-quarter 2019 contract drilling revenue was $65.9 million, which included $3.4 million in reimbursable revenue and $0.6 million of deferred revenue amortization. This compared to fourth-quarter 2018 contract drilling revenue of $59.6 million, which included $1.4 million in reimbursable revenue and $2.9 million of deferred revenue amortization. The increase in revenue resulted primarily from the Pacific Bora operating for the full quarter under the contract with Nigerian Agip Exploration Limited, a subsidiary of Eni, compared to only a portion of the period in fourth-quarter 2018.
Operating expenses for the first quarter of 2019 were $52.3 million compared to $44.8 million in the fourth quarter of 2018. The increase in operating expenses was primarily due to costs of the Pacific Santa Ana ramping up to commence its contract with Total E&P Senegal in Senegal. Additionally, operating expenses included reimbursable revenue expenses for first-quarter 2019 of $2.4 million compared to $1.1 million in fourth-quarter 2018.
General and administrative expenses for the first quarter of 2019 were $11.2 million, as compared to $13.8 million for the fourth quarter of 2018. The decrease in general and administrative expenses was primarily due to the impact of a heightened emphasis on cost control and process optimization.
Adjusted EBITDA(a) for first-quarter 2019 was $4.3 million, compared to $3.3 million in fourth-quarter 2018.
Capital expenditures for the first quarter of 2019 were $17.6 million compared to $6.2 million in the fourth quarter of 2018. The increase in capital expenditures was primarily due to payments made to date to purchase a managed pressure drilling device and controls.
Footnotes
|
(a) |
EBITDA and Adjusted EBITDA are non-GAAP financial measures. For a definition of EBITDA and Adjusted EBITDA and a reconciliation to net income, please refer to the schedule included in this release. Management uses this operational metric to track company results and believes that this measure provides additional information that highlights the impact of our operating efficiency as well as the operating and support costs incurred in achieving the revenue performance. |
2019 Guidance
A schedule of Pacific Drilling’s 2019 guidance as of May 13, 2019 is available in the “Quarterly and Annual Results” subsection of the “Investor Relations” section of our website, www.pacificdrilling.com .
Conference Call
Pacific Drilling will conduct a conference call at 10 a.m. Central time on Tuesday, May 14, 2019 to discuss first-quarter 2019 results. To access the conference call, participants should contact the Conference Call Operator at +1 888-221-3881 within North America or +1 720-452-9217 outside of North America approximately 10 minutes prior to the scheduled start time and provide confirmation code #4796567. A replay of the call will be available on the company’s website or by dialing +1 888-203-1112 within North America or +1 719-457-0820 outside of North America and providing confirmation code #4796567.
About Pacific Drilling
With its best-in-class drillships and highly experienced team, Pacific Drilling is committed to becoming the industry’s preferred high-specification, deepwater drilling contractor. Pacific Drilling’s fleet of seven drillships represents one of the youngest and most technologically advanced fleets in the world. Pacific Drilling has principal offices in Luxembourg and Houston. For more information about Pacific Drilling, including our current Fleet Status, please visit our website at www.pacificdrilling.com .
Forward-Looking Statements
Certain statements and information contained in this press release constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and are generally identifiable by their use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “our ability to,” “may,” “plan,” “potential,” “predict,” “project,” “projected,” “should,” “will,” “would”, or other similar words which are not generally historical in nature. The forward-looking statements speak only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise.
Our forward-looking statements express our current expectations or forecasts of possible future results or events, including future financial and operational performance and cash balances; revenue efficiency levels; market outlook; forecasts of trends; future client contract opportunities; future contract dayrates; our business strategies and plans or objectives of management; estimated duration of client contracts; backlog; expected capital expenditures; projected costs and savings; and the potential impact of our completed Chapter 11 proceedings on our future operations and ability to finance our business.
Although we believe that the assumptions and expectations reflected in our forward-looking statements are reasonable and made in good faith, these statements are not guarantees, and actual future results may differ materially due to a variety of factors. These statements are subject to a number of risks and uncertainties and are based on a number of judgments and assumptions as of the date such statements are made about future events, many of which are beyond our control. Actual events and results may differ materially from those anticipated, estimated, projected or implied by us in such statements due to a variety of factors, including if one or more of these risks or uncertainties materialize, or if our underlying assumptions prove incorrect.
Important factors that could cause actual results to differ materially from our expectations include: the global oil and gas market and its impact on demand for our services; the offshore drilling market, including reduced capital expenditures by our clients; changes in worldwide oil and gas supply and demand; rig availability and supply and demand for high-specification drillships and other drilling rigs competing with our fleet; our ability to enter into and negotiate favorable terms for new drilling contracts or extensions; our ability to successfully negotiate and consummate definitive contracts and satisfy other customary conditions with respect to letters of intent and letters of award that we receive for our drillships; possible cancellation, renegotiation, termination or suspension of drilling contracts as a result of mechanical difficulties, performance, market changes or other reasons; costs related to stacking of rigs; downtime and other risks associated with offshore rig operations, including unscheduled repairs or maintenance, relocations, severe weather or hurricanes; our small fleet and reliance on a limited number of clients; our ability to execute our business plans; the effects of our completed Chapter 11 proceedings on our future operations; and the other risk factors described in our 2018 Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 12, 2019 and our Reports on Form 6-K. These documents are available through our website at www.pacificdrilling.com or through the SEC’s website at www.sec.gov .
|
PACIFIC DRILLING S.A. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (in thousands, except per share information) (unaudited) |
||||||||||||||||||||||
| Successor | Predecessor | |||||||||||||||||||||
| Period from | Period from | |||||||||||||||||||||
| Three Months | November 20, | October 1, | Three Months | |||||||||||||||||||
| Ended March 31, | through | through | Ended March 31, | |||||||||||||||||||
| 2019 | December 31, 2018 | November 19, 2018 | 2018 | |||||||||||||||||||
| Revenues | ||||||||||||||||||||||
| Contract drilling | $ | 65,916 | $ | 28,489 | $ | 31,073 | $ | 82,069 | ||||||||||||||
| Costs and expenses | ||||||||||||||||||||||
| Operating expenses | (52,296 | ) | (19,744 | ) | (25,050 | ) | (64,354 | ) | ||||||||||||||
| General and administrative expenses | (11,246 | ) | (4,245 | ) | (9,572 | ) | (17,204 | ) | ||||||||||||||
| Depreciation and amortization expense | (58,899 | ) | (27,277 | ) | (38,187 | ) | (69,920 | ) | ||||||||||||||
| (122,441 | ) | (51,266 | ) | (72,809 | ) | (151,478 | ) | |||||||||||||||
| Operating loss | (56,525 | ) | (22,777 | ) | (41,736 | ) | (69,409 | ) | ||||||||||||||
| Other income (expense) | ||||||||||||||||||||||
| Interest expense | (24,039 | ) | (10,904 | ) | (29,046 | ) | (14,929 | ) | ||||||||||||||
| Reorganization items | (1,003 | ) | (1,300 | ) | (1,743,556 | ) | (12,032 | ) | ||||||||||||||
| Interest income | 1,972 | 1,008 | 428 | 788 | ||||||||||||||||||
| Equity earnings in unconsolidated subsidiaries | (1,052 | ) | 392 | — | — | |||||||||||||||||
| Expenses to unconsolidated subsidiaries, net | (272 | ) | (1,198 | ) | — | — | ||||||||||||||||
| Other income (expense) | (91 | ) | 526 | 350 | (195 | ) | ||||||||||||||||
| Loss before income taxes | (81,010 | ) | (34,253 | ) | (1,813,560 | ) | (95,777 | ) | ||||||||||||||
| Income tax (expense) benefit | (2,969 | ) | 6,769 | 3,261 | (274 | ) | ||||||||||||||||
| Net loss | $ | (83,979 | ) | $ | (27,484 | ) | $ | (1,810,299 | ) | $ | (96,051 | ) | ||||||||||
| Loss per common share, basic | $ | (1.12 | ) | $ | (0.37 | ) | $ | (84.72 | ) | $ | (4.50 | ) | ||||||||||
| Weighted average number of common shares, basic | 75,031 | 75,010 | 21,368 | 21,339 | ||||||||||||||||||
| Loss per common share, diluted | $ | (1.12 | ) | $ | (0.37 | ) | $ | (84.72 | ) | $ | (4.50 | ) | ||||||||||
| Weighted average number of common shares, diluted | 75,031 | 75,010 | 21,368 | 21,339 | ||||||||||||||||||
|
PACIFIC DRILLING S.A. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (in thousands) (unaudited) |
|||||||||||||
| March 31, | December 31, | ||||||||||||
| 2019 | 2018 | ||||||||||||
| Assets: | |||||||||||||
| Cash and cash equivalents | $ | 337,173 | $ | 367,577 | |||||||||
| Restricted cash | 16,965 | 21,498 | |||||||||||
| Accounts receivable, net | 46,895 | 40,549 | |||||||||||
| Other receivable | 28,000 | 28,000 | |||||||||||
| Materials and supplies | 40,598 | 40,429 | |||||||||||
| Prepaid expenses and other current assets | 16,390 | 9,149 | |||||||||||
| Total current assets | 486,021 | 507,202 | |||||||||||
| Property and equipment, net | 1,901,540 | 1,915,172 | |||||||||||
| Receivable from unconsolidated subsidiaries | 204,790 | 204,790 | |||||||||||
| Intangible asset | 53,025 | 85,053 | |||||||||||
| Investment in unconsolidated subsidiaries | 11,264 | 11,876 | |||||||||||
| Other assets | 29,630 | 24,120 | |||||||||||
| Total assets | $ | 2,686,270 | $ | 2,748,213 | |||||||||
| Liabilities and shareholders’ equity: | |||||||||||||
| Accounts payable | $ | 13,072 | $ | 14,941 | |||||||||
| Accrued expenses | 17,716 | 25,744 | |||||||||||
| Accrued interest | 32,279 | 16,576 | |||||||||||
| Deferred revenue, current | 1,443 | — | |||||||||||
| Total current liabilities | 64,510 | 57,261 | |||||||||||
| Long-term debt | 1,047,431 | 1,039,335 | |||||||||||
| Payable to unconsolidated subsidiaries | 4,381 | 4,400 | |||||||||||
| Other long-term liabilities | 34,228 | 28,259 | |||||||||||
| Total liabilities | 1,150,550 | 1,129,255 | |||||||||||
| Shareholders’ equity: | |||||||||||||
| Common shares | 750 | 750 | |||||||||||
| Additional paid-in capital | 1,646,557 | 1,645,692 | |||||||||||
| Treasury shares, at cost | (124 | ) | — | ||||||||||
| Accumulated deficit | (111,463 | ) | (27,484 | ) | |||||||||
| Total shareholders’ equity | 1,535,720 | 1,618,958 | |||||||||||
| Total liabilities and shareholders’ equity | $ | 2,686,270 | $ | 2,748,213 | |||||||||
|
PACIFIC DRILLING S. A. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) |
|||||||||||||||||||||||||
| Successor | Predecessor | ||||||||||||||||||||||||
| Period From | Period From | ||||||||||||||||||||||||
| Three Months | November 20, | October 1, | Three Months | ||||||||||||||||||||||
| Ended March 31, | through | through | Ended March 31, | ||||||||||||||||||||||
| 2019 | December 31, 2018 | November 19, 2018 | 2018 | ||||||||||||||||||||||
| Cash flow from operating activities: | |||||||||||||||||||||||||
| Net loss | $ | (83,979 | ) | $ | (27,484 | ) | $ | (1,810,299 | ) | $ | (96,051 | ) | |||||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||||||||||
| Depreciation and amortization expense | 58,899 | 27,277 | 38,187 | 69,920 | |||||||||||||||||||||
| Amortization of deferred revenue | (570 | ) | — | (2,890 | ) | (6,150 | ) | ||||||||||||||||||
| Amortization of deferred costs | 433 | 128 | 1,645 | 5,007 | |||||||||||||||||||||
| Amortization of deferred financing costs | — | — | 1,639 | — | |||||||||||||||||||||
| Amortization of debt premium, net | (112 | ) | (38 | ) | — | — | |||||||||||||||||||
| Interest paid-in-kind | 8,208 | 3,732 | 4,477 | — | |||||||||||||||||||||
| Deferred income taxes | 2,765 | (6,507 | ) | 7,172 | (1,762 | ) | |||||||||||||||||||
| Share-based compensation expense | 865 | 599 | 932 | 723 | |||||||||||||||||||||
| Reorganization items | — | — | 1,724,494 | 4,707 | |||||||||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||||||||||
| Accounts receivable | (6,346 | ) | (11,670 | ) | 6,096 | (8,284 | ) | ||||||||||||||||||
| Materials and supplies | (169 | ) | (122 | ) | 499 | 1,109 | |||||||||||||||||||
| Prepaid expenses and other assets | (14,222 | ) | (11,177 | ) | (39,254 | ) | 4,451 | ||||||||||||||||||
| Accounts payable and accrued expenses | 16,130 | (16,490 | ) | (20,808 | ) | (12,745 | ) | ||||||||||||||||||
| Deferred revenue | 2,013 | — | — | (1,535 | ) | ||||||||||||||||||||
| Net cash used in operating activities | (16,085 | ) | (41,752 | ) | (88,110 | ) | (40,610 | ) | |||||||||||||||||
| Cash flow from investing activities: | |||||||||||||||||||||||||
| Capital expenditures | (17,613 | ) | (2,697 | ) | (3,544 | ) | (3,888 | ) | |||||||||||||||||
| Deconsolidation of Zonda Debtors | — | — | (4,910 | ) | — | ||||||||||||||||||||
| Net cash used in investing activities | (17,613 | ) | (2,697 | ) | (8,454 | ) | (3,888 | ) | |||||||||||||||||
| Cash flow from financing activities: | |||||||||||||||||||||||||
| Payments for shares issued under share-based compensation plan | — | (126 | ) | — | — | ||||||||||||||||||||
| Payments from debtor-in-possession financing | — | — | (50,000 | ) | — | ||||||||||||||||||||
| Payments on long-term debt | — | — | (1,136,478 | ) | — | ||||||||||||||||||||
| Proceeds from equity offerings | — | — | 500,000 | — | |||||||||||||||||||||
| Payments for financing costs | (1,115 | ) | (13,525 | ) | (1,933 | ) | — | ||||||||||||||||||
| Purchases of treasury shares | (124 | ) | — | — | — | ||||||||||||||||||||
| Net cash used in financing activities | (1,239 | ) | (13,651 | ) | (688,411 | ) | — | ||||||||||||||||||
| Net decrease in cash and cash equivalents | (34,937 | ) | (58,100 | ) | (784,975 | ) | (44,498 | ) | |||||||||||||||||
| Cash, cash equivalents and restricted cash, beginning of period | 389,075 | 447,175 | 1,232,150 | 317,448 | |||||||||||||||||||||
| Cash, cash equivalents and restricted cash, end of period | $ | 354,138 | $ | 389,075 | $ | 447,175 | $ | 272,950 | |||||||||||||||||
EBITDA and Adjusted EBITDA Reconciliation
EBITDA is defined as earnings before interest expense, taxes, depreciation and amortization. Adjusted EBITDA is defined as earnings before interest expense, taxes, depreciation, amortization, equity earnings in unconsolidated subsidiaries, expenses to unconsolidated subsidiaries, net and reorganization items. EBITDA and Adjusted EBITDA do not represent and should not be considered an alternative to net income, operating income, cash flow from operations or any other measure of financial performance presented in accordance with U.S. generally accepted accounting principles (“GAAP”) and our calculation of EBITDA and Adjusted EBITDA may not be comparable to that reported by other companies. EBITDA and Adjusted EBITDA are included herein because they are used by management to measure the Company’s operations. Management believes that EBITDA and Adjusted EBITDA present useful information to investors regarding the Company’s operating performance.
|
PACIFIC DRILLING S.A. AND SUBSIDIARIES
Supplementary Data—Reconciliation of Net Loss to Non-GAAP EBITDA and Adjusted EBITDA (in thousands) (unaudited) |
||||||||||||||||||||||
| Successor | Predecessor | |||||||||||||||||||||
| Period From | Period From | |||||||||||||||||||||
| Three Months | November 20, | October 1, | Three Months | |||||||||||||||||||
| Ended | through | through | Ended | |||||||||||||||||||
| March 31, | December 31, | November 19, | March 31, | |||||||||||||||||||
| 2019 | 2018 | 2018 | 2018 | |||||||||||||||||||
| Net loss | $ | (83,979 | ) | $ | (27,484 | ) | $ | (1,810,299 | ) | $ | (96,051 | ) | ||||||||||
| Add: | ||||||||||||||||||||||
| Interest expense | 24,039 | 10,904 | 29,046 | 14,929 | ||||||||||||||||||
| Depreciation and amortization expense | 58,899 | 27,277 | 38,187 | 69,920 | ||||||||||||||||||
| Income tax expense (benefit) | 2,969 | (6,769 | ) | (3,261 | ) | 274 | ||||||||||||||||
| EBITDA | $ | 1,928 | $ | 3,928 | $ | (1,746,327 | ) | $ | (10,928 | ) | ||||||||||||
| Add: | ||||||||||||||||||||||
| Equity earnings in unconsolidated subsidiaries | 1,052 | (392 | ) | — | — | |||||||||||||||||
| Expenses to unconsolidated subsidiaries, net | 272 | 1,198 | — | — | ||||||||||||||||||
| Reorganization items | 1,003 | 1,300 | 1,743,556 | 12,032 | ||||||||||||||||||
| Adjusted EBITDA | $ | 4,255 | $ | 6,034 | $ | (2,771 | ) | $ | 1,104 | |||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190513005841/en/
Contact:
Investor Contact: Johannes (John) P. Boots Pacific Drilling S.A. +713 334 6662 Investor@pacificdrilling.com Media Contact: Amy L. Roddy Pacific Drilling S.A. +713 334 6662 Media@pacificdrilling.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
